Shares of telehealth-technology provider Teladoc Health Inc. TDOC sank after hours on Tuesday following a largely downbeat forecast for the first quarter and full year. The company, known for its BetterHelp therapy app, said it expected first-quarter sales of $630 million to $645 million, below FactSet forecasts of $673 million. It said it expected to lose 45 cents a share to 55 cents a share during that period, worse than analyst expectations for a 41-cent per-share loss. For the full year, Teladoc said i ...

The so-called "pandemic stocks" are a group of companies that performed well during the early days of the coronavirus outbreak since, for whatever reason, their businesses were equipped to thrive in these highly unusual conditions. Telehealth specialist Teladoc Health (TDOC -3.23%) was one of them. The company provided a convenient way for patients to get medical care without leaving their homes.However, like many other pandemic stocks, Teladoc has been on a southbound spiral since early 2021. The company's ...

公司业绩电话会议 - Teladoc Health, Inc.宣布调整2023年第四季度业绩电话会议时间，延迟至2024年2月20日下午5:00 E.T.举行[1] - 参与者可通过拨打1-833-470-1428（美国参与者）并使用访问代码 825968，或访问链接https://www.netroadshow.com/conferencing/global-numbers?confId=60046（国际参与者）参与电话会议[2] - 电话会议结束后，可通过网页重播收听，链接与原直播链接相同，将保持约90天的可用性[3] 公司业务 - Teladoc Health是全球整体虚拟医疗护理领域的领导者，利用专有的健康信号和个性化互动，推动在整个护理连续体中实现更好的健康结果[4]

Teladoc Health, Inc. (TDOC)第四季度业绩预测 - 预计第四季度每股亏损为22美分，较去年同期的23美分有所改善[1] - 预计第四季度营收为6.708亿美元，较去年同期增长5.2%[1] - Teladoc在过去四个季度中均超过了盈利的共识预期，平均超过14.2%[1] Teladoc Health, Inc. (TDOC)第四季度业绩影响因素 - 第四季度结果可能受益于更高的访问费用、访问量增加以及整合护理和BetterHelp部门的增长[4] - 第四季度的访问费用预期将比去年同期增加6.5%[5] - 第四季度的总访问量预计将同比增长3.5%[6] Teladoc Health, Inc. (TDOC)第四季度营收预测 - 预计第四季度美国营收将同比增长近5%，国际营收预计将增长超过10%[7] - 预计BetterHelp的调整后EBITDA将同比增长超过24%[7] - 预计其他收入将同比减少1.5%[9] Teladoc Health, Inc. (TDOC)第四季度总体预测 - 公司预计第四季度总收入为6.58亿至6.83亿美元，调整后EBITDA为1.07亿至1.17亿美元[10] - 公司的盈利预期不确定，因为盈利ESP为0.00%，并且Zacks排名为2[12] 其他医疗公司比较 - 公司建议考虑一些其他医疗公司，如Amedisys, Inc. (AMED)和Globus Medical, Inc. (GMED)[14][15] - Amedisys的盈利预期为每股1.04美元，过去四个季度中有三次超过盈利预期[15] - Globus Medical的盈利预期为每股59美分，过去四个季度中均超过盈利预期[16]

Vertex Pharmaceuticals - Vertex Pharmaceuticals在过去12个月的总回报大约是标普500指数的两倍，股价比一年前高出40%[4] - Vertex Pharmaceuticals通过其治疗囊性纤维化的四种产品去年创造了近100亿美元的收入，同时也报告了约36亿美元的利润[6] Teladoc Health - Teladoc Health在过去几年经历了一些困难，但其净亏损已经大幅缩减，第三季度的营收同比增长了8%[16]

urbazon/E+ via Getty ImagesIntroduction and Investment Thesis Teladoc (NYSE:TDOC) is a virtual healthcare services company that has severely underperformed the indices over the last 2 years. However, the latest earnings call suggests there is growing evidence of Teladoc’s renewed focus on improving its overall profitability, as Adjusted EBITDA grew 73% YoY. While investors are still wary about competitive threats from legacy players as well as technology giants such as Amazon (NASDAQ:AMZN) and Walmart ( ...

Last year was a big one for most growth stocks, but Teladoc Health (TDOC -1.05%) didn't participate in the rally. Shares of America's largest telehealth provider dropped 9% in 2023 and are down 6% so far this year.If we look back a little further, we can see the stock is down more than 90% from the peak it reached almost three years ago.You wouldn't know it by looking at its stock chart, but Teladoc Health is a much larger business than it was a few years ago. Could now be the right time to buy this beaten- ...

The latest trading session saw Teladoc (TDOC) ending at $20.24, denoting a +1.96% adjustment from its last day's close. The stock's change was more than the S&P 500's daily gain of 1.23%. Elsewhere, the Dow gained 1.06%, while the tech-heavy Nasdaq added 1.7%.The the stock of telehealth services provider has fallen by 6.72% in the past month, lagging the Medical sector's gain of 3.16% and the S&P 500's gain of 0.94%.The investment community will be paying close attention to the earnings performance of Telad ...

PURCHASE, NY, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE:TDOC), the global leader in whole-person virtual care, today published its fourth annual Corporate Social Responsibility (CSR) report. The latest report highlights the organization's growing positive impact on communities around the globe—from expanding access to equitable care and advancing health equity, to further reducing packaging materials to support sustainability goals. It also follows a landmark year for the company, which surpass ...

Teladoc Health股价表现 - Teladoc Health 最近股价上涨18%，投资者开始重新看好这支股票[1] Teladoc业绩表现 - Teladoc 在2020年收购 Livongo 时支付了高昂的价格，导致公司遭受数十亿美元的减值损失，但在2023年前九个月，减值损失不再拖累其业绩，营收增长近10%[3][4] 远程医疗市场前景 - 分析师预计到2030年，远程医疗市场价值将达到4553亿美元，是目前市值的3倍以上，增长率为24.3%[7] Teladoc长期增长机会 - 远程医疗行业仍然充满机遇，Teladoc 作为行业内的大公司，有望从长期增长中受益[11][12]